260 related articles for article (PubMed ID: 32788348)
1. Negative MAPK-ERK regulation sustains CIC-DUX4 oncoprotein expression in undifferentiated sarcoma.
Lin YK; Wu W; Ponce RK; Kim JW; Okimoto RA
Proc Natl Acad Sci U S A; 2020 Aug; 117(34):20776-20784. PubMed ID: 32788348
[TBL] [Abstract][Full Text] [Related]
2. CIC-DUX4 oncoprotein drives sarcoma metastasis and tumorigenesis via distinct regulatory programs.
Okimoto RA; Wu W; Nanjo S; Olivas V; Lin YK; Ponce RK; Oyama R; Kondo T; Bivona TG
J Clin Invest; 2019 Jul; 129(8):3401-3406. PubMed ID: 31329165
[TBL] [Abstract][Full Text] [Related]
3. Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewing-like sarcomas with t(4;19)(q35;q13) translocation.
Kawamura-Saito M; Yamazaki Y; Kaneko K; Kawaguchi N; Kanda H; Mukai H; Gotoh T; Motoi T; Fukayama M; Aburatani H; Takizawa T; Nakamura T
Hum Mol Genet; 2006 Jul; 15(13):2125-37. PubMed ID: 16717057
[TBL] [Abstract][Full Text] [Related]
4. Round cell sarcoma with CIC-DUX4 gene fusion: Discussion of the distinctive cytomorphologic, immunohistochemical, and molecular features in the differential diagnosis of round cell tumors.
Chebib I; Jo VY
Cancer Cytopathol; 2016 May; 124(5):350-61. PubMed ID: 26800124
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological features of five cases of CIC::DUX4 positive sarcomas, including literature review.
Rekhi B; Rumdee R; Shetty O
Ann Diagn Pathol; 2023 Aug; 65():152153. PubMed ID: 37167753
[TBL] [Abstract][Full Text] [Related]
6. High prevalence of CIC fusion with double-homeobox (DUX4) transcription factors in EWSR1-negative undifferentiated small blue round cell sarcomas.
Italiano A; Sung YS; Zhang L; Singer S; Maki RG; Coindre JM; Antonescu CR
Genes Chromosomes Cancer; 2012 Mar; 51(3):207-18. PubMed ID: 22072439
[TBL] [Abstract][Full Text] [Related]
7. Primary undifferentiated small round cell sarcoma of the deep abdominal wall with a novel variant of t(10;19) CIC-DUX4 gene fusion.
Tsukamoto Y; Futani H; Yoshiya S; Watanabe T; Kihara T; Matsuo S; Hirota S
Pathol Res Pract; 2017 Oct; 213(10):1315-1321. PubMed ID: 28645808
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic features of undifferentiated round cell sarcomas of bone & soft tissues: An attempt to unravel the
Rekhi B; Kembhavi P; Mishra SN; Shetty O; Bajpai J; Puri A
Indian J Med Res; 2019 Dec; 150(6):557-574. PubMed ID: 32048619
[TBL] [Abstract][Full Text] [Related]
9. The CIC-DUX4 fusion transcript is present in a subgroup of pediatric primitive round cell sarcomas.
Graham C; Chilton-MacNeill S; Zielenska M; Somers GR
Hum Pathol; 2012 Feb; 43(2):180-9. PubMed ID: 21813156
[TBL] [Abstract][Full Text] [Related]
10. Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma.
Carrabotta M; Laginestra MA; Durante G; Mancarella C; Landuzzi L; Parra A; Ruzzi F; Toracchio L; De Feo A; Giusti V; Pasello M; Righi A; Lollini PL; Palmerini E; Donati DM; Manara MC; Scotlandi K
Cancer Res; 2022 Feb; 82(4):708-720. PubMed ID: 34903601
[TBL] [Abstract][Full Text] [Related]
11. Sarcomas With CIC-rearrangements Are a Distinct Pathologic Entity With Aggressive Outcome: A Clinicopathologic and Molecular Study of 115 Cases.
Antonescu CR; Owosho AA; Zhang L; Chen S; Deniz K; Huryn JM; Kao YC; Huang SC; Singer S; Tap W; Schaefer IM; Fletcher CD
Am J Surg Pathol; 2017 Jul; 41(7):941-949. PubMed ID: 28346326
[TBL] [Abstract][Full Text] [Related]
12. Distinct transcriptional signature and immunoprofile of CIC-DUX4 fusion-positive round cell tumors compared to EWSR1-rearranged Ewing sarcomas: further evidence toward distinct pathologic entities.
Specht K; Sung YS; Zhang L; Richter GH; Fletcher CD; Antonescu CR
Genes Chromosomes Cancer; 2014 Jul; 53(7):622-33. PubMed ID: 24723486
[TBL] [Abstract][Full Text] [Related]
13. Histological and immunohistochemical characteristics of undifferentiated small round cell sarcomas associated with CIC-DUX4 and BCOR-CCNB3 fusion genes.
Yamada Y; Kuda M; Kohashi K; Yamamoto H; Takemoto J; Ishii T; Iura K; Maekawa A; Bekki H; Ito T; Otsuka H; Kuroda M; Honda Y; Sumiyoshi S; Inoue T; Kinoshita N; Nishida A; Yamashita K; Ito I; Komune S; Taguchi T; Iwamoto Y; Oda Y
Virchows Arch; 2017 Apr; 470(4):373-380. PubMed ID: 28197724
[TBL] [Abstract][Full Text] [Related]
14. Expanding the Molecular Diversity of CIC-Rearranged Sarcomas With Novel and Very Rare Partners.
Linos K; Dermawan JK; Bale T; Rosenblum MK; Singer S; Tap W; Dickson MA; Hornick JL; Antonescu CR
Mod Pathol; 2023 May; 36(5):100103. PubMed ID: 36788092
[TBL] [Abstract][Full Text] [Related]
15. Ewing-like sarcoma with CIC-DUX4 gene fusion in a patient with neurofibromatosis type 1. A hitherto unreported association.
Tardío JC; Machado I; Navarro L; Idrovo F; Sanz-Ortega J; Pellín A; Llombart-Bosch A
Pathol Res Pract; 2015 Nov; 211(11):877-82. PubMed ID: 26386605
[TBL] [Abstract][Full Text] [Related]
16. Distinct histologic and genetic characteristics of round cell sarcoma with CIC-DUX4 fusion and comparison with ewing sarcoma.
Song MJ; Cho KJ; Kim TI; Kim W; Song JS
Pathol Res Pract; 2022 Mar; 231():153779. PubMed ID: 35151033
[TBL] [Abstract][Full Text] [Related]
17. Superficial sarcomas with CIC rearrangement are aggressive neoplasms: A series of eight cases.
Ko JS; Marusic Z; Azzato EM; Farkas DH; Van Arnam J; Seiwerth S; Fritchie K; Patel RM; Rubin BP; Billings SD
J Cutan Pathol; 2020 Jun; 47(6):509-516. PubMed ID: 32026485
[TBL] [Abstract][Full Text] [Related]
18.
Yoshimoto T; Tanaka M; Homme M; Yamazaki Y; Takazawa Y; Antonescu CR; Nakamura T
Cancer Res; 2017 Jun; 77(11):2927-2937. PubMed ID: 28404587
[No Abstract] [Full Text] [Related]
19. Undifferentiated small round cell sarcoma with t(4;19)(q35;q13.1) CIC-DUX4 fusion: a novel highly aggressive soft tissue tumor with distinctive histopathology.
Choi EY; Thomas DG; McHugh JB; Patel RM; Roulston D; Schuetze SM; Chugh R; Biermann JS; Lucas DR
Am J Surg Pathol; 2013 Sep; 37(9):1379-86. PubMed ID: 23887164
[TBL] [Abstract][Full Text] [Related]
20. WEE1 kinase is a therapeutic vulnerability in CIC-DUX4 undifferentiated sarcoma.
Ponce RKM; Thomas NJ; Bui NQ; Kondo T; Okimoto RA
JCI Insight; 2022 Mar; 7(6):. PubMed ID: 35315355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
